| Antibiotics |
1 |
1 |
| COVID-19 |
0 |
0.98 |
| Pandemic |
0 |
0.99 |
| Pandemic Influenza |
0 |
0.59 |
| Antimicrobial Resistance |
0 |
0.35 |
| Microbicides |
0 |
0.33 |
| Revenue and Practice Management |
0 |
0.97 |
| Hospital-Acquired Infection |
0 |
0.32 |
| Antimicrobial Stewardship |
0 |
0.28 |
| Hospital |
0 |
0.28 |
| Bacteria |
0 |
0.17 |
| Clinical Guidelines |
0 |
0.17 |
| Stem Cell Research and Therapy |
0 |
0.13 |
| Society for Healthcare Epidemiology of America |
0 |
0.12 |
| Epidemiology |
0 |
0.11 |
| Grant |
0 |
0.11 |
| Meta-Analysis |
0 |
0.11 |
| Salary and Compensation |
0 |
0.11 |
| Influenza |
0 |
0.1 |
| Middle Eastern Respiratory Syndrome (MERS) |
0 |
0.1 |
| Acinetobacter |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Critical Illness |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Fungal Infection |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Infection Control |
0 |
0.06 |
| Inpatient Care |
0 |
0.06 |
| Outbreak |
0 |
0.06 |
| Transplantation |
0 |
0.06 |